CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
53.59
-0.13 (-0.24%)
Jun 8, 2026, 11:13 AM EDT - Market open
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $4.73 billion as of June 8, 2026. Its market cap has increased by 136.50% in one year.
Market Cap
4.73B
Enterprise Value
3.67B
1-Year Change
136.50%
Ranking
Category
Stock Price
$53.59
Market Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $4.73B, an increase of 291.88%. That is a compound annual growth rate of 78.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 4.74B | 41.47% |
| Dec 31, 2025 | 3.35B | 53.40% |
| Dec 31, 2024 | 2.18B | 81.02% |
| Jan 25, 2024 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TG Therapeutics | 5.69B |
| Belite Bio | 5.64B |
| Scholar Rock Holding | 5.31B |
| Cogent Biosciences | 5.30B |
| Xenon Pharmaceuticals | 5.00B |
| CRISPR Therapeutics AG | 5.00B |
| Ligand Pharmaceuticals | 4.75B |
| Caris Life Sciences | 4.66B |